杨贵妃传媒視頻

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 杨贵妃传媒視頻 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Apr 27 2022

Full Issue

'No Net Benefit': Daily Aspirin For Most Now Discouraged By Task Force

The U.S. Preventive Services Task Force released a report that finds little to no benefit for people without cardiovascular disease in preventing a heart attack or stroke. And there is an increased risk of bleeding. Based on the evidence, the panel's new guidance says people 60 and up should not start taking daily low-dose aspirin.

New guidance from the U.S. Preventive Services Task Force says people over the age of 60 should not start taking daily, low-dose aspirin to prevent cardiovascular events like heart attacks or strokes. Low-dose aspirin had been a popular prevention measure, but as more evidence has accumulated its benefit has come into question. On Tuesday the task force finalized new recommendations advising against the practice. The task force concludes that initiating daily aspirin in adults 60 years or older has "no net benefit," and increases a person's risk of internal bleeding. (Aubrey and Stone, 4/26)

Taking low-dose aspirin every day to prevent a heart attack or stroke provides little to no benefit to people without cardiovascular disease but could instead increase the risk of dangerous bleeding, a new report from the U.S. Preventive Services Task Force says. For adults ages 60 and up who don鈥檛 have cardiovascular disease or aren鈥檛 at high risk of developing it, the task force determined there was no benefit to starting aspirin if they are not already on it. Among adults 40 to 59 years old, the task force, a volunteer group of medical experts, concluded 鈥渨ith moderate certainty鈥 that there was a small net benefit to taking low-dose aspirin among those who have a 10% or higher risk of developing heart disease in a 10-year period. It鈥檚 up to those individuals and their doctors to decide whether to take aspirin, the task force concluded. (Cueto, 4/26)

For years, doctors recommended people in their 50s start taking baby aspirin every day to protect against heart attacks and stroke. But in recent years, with new evidence of the possible harm of daily aspirin, health experts shifted those recommendations. In major new guidance, an influential physician task force no longer recommends daily aspirin to prevent a first heart attack or stroke among people 60 and older. Meanwhile, the new guidance said people 40 to 59 should only take it if they have a high risk of cardiovascular disease, and in consultation with a doctor. There is little benefit in continuing aspirin beyond the age of 75 years old, experts concluded. (Akusoba, 4/26)

If you are between 40 and 59 years old, the USPSTF leaves it up to you and your doctor to decide whether you should take a daily aspirin in specific circumstances. "If you are really healthy, if you're a healthy 40-year-old with no major risk factors, you will do more harm than good with daily aspirin. Your risk of bleeding will exceed the benefits," said Dr. Steven Nissen, chair of cardiovascular medicine at Cleveland Clinic, who was not involved in the new guidelines. "People need to understand that aspirin is not a completely benign or innocent therapy." (Christensen, 4/26)

The guidance from the U.S. Preventive Services Task Force was strongly influenced by Bloomington-based HealthPartners, which used computer models to weigh aspirin's preventive benefits of reducing heart attacks and strokes vs. its risk of causing bleeding. The task force no longer advises anyone to initiate aspirin without talking to their doctor, but the update to its 2016 guidance doesn't extend to the 30 million Americans already taking the pills to reduce cardiac risks. "We found from our modeling study that the balance between potential benefits and harms is narrower," said Steven Dehmer, a health economist with HealthPartners Institute who led the research. (Olson, 4/26)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Monday, June 1
  • Friday, May 29
  • Thursday, May 28
  • Wednesday, May 27
  • Tuesday, May 26
  • Friday, May 22
More Morning Briefings
RSS Feeds
  • 杨贵妃传媒視頻
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF